Nasal Drug Delivery Technology Market Witness Highest Growth Of USD 67.99 Billion By 2025: Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.

According to a report, Nasal Drug Delivery Technology Market Analysis Report By Therapeutic Application (Asthma, Rhinitis), By Dosage Form (Powder, Gel, Spray, Drops), By Container Type, And Segment Forecasts, 2019 – 2025 published by Grand View Research, Inc., The global nasal drug delivery systems market size is expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR, Rising awareness about nasal products is one of the major factors driving the market. Growing geriatric population is also expected to have positive impact on the market. According to the United Nations Department of Economic and Social Affairs, the global geriatric population (60 years and above), was around 962 million in 2017. The number is expected to grow, particularly in Latin America with 71% rise in population aged 60 and over, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%).

Key Takeaways from the report:

• Nasal sprays led the dosage type segment in 2017 due to increased prevalence of asthma and other infectious diseases

• On the other hand, nasal drops segment witnessed the fastest growth in 2017 owing to availability of cost-effective products with better efficacy

• Non-pressurized containers segment led the market in 2017 due to continous development in nasal powders and gel products

• Asthma was the dominant therapeutic application segment in 2017 and is estimated to be the fastest-growing segment with a CAGR of 7.0% during the forecast years due to increasing disease prevalence

• Geographically, North America held the largest share in 2017. Asia Pacific is estimated to witness the fastest CAGR of 7.5% due to presence of key companies, such as Cipla Inc.

• Some of the leading companies in the global nasal drug delivery technology market are GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; and NAVEH Pharma Ltd.

Browse More Reports in Pharmaceuticals Industry:

• Precision Medicine (Diagnostics/Therapeutics) Market: Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting Precision Medicine (Diagnostics/Therapeutics) Market growth.

• Nuclear Medicine Market: Need for early and accurate diagnostic methods, coupled with growing demand for better therapies, is driving the Nuclear Medicine Market. Increasing incidence of cancer and cardiovascular disorders is also contributing toward market growth as nuclear medicine has proven rather accurate in the diagnosis and treatment of such conditions.

Moreover, ongoing product development and their expected commercialization will propel market growth over the forecast period. For instance, In April 2018, Dr. Reddy’s Laboratories, along with its subsidiary Promius Pharma, LLC, announced filing of their New Drug Application (NDA) for DFN-02, for the treatment of migraine. Increasing adoption of self-administration practices and focus on other alternative routes of drug delivery, such as nasal drug delivery, also offer growth opportunities for the market. Some of the key companies in the industry are AstraZeneca PLC; OptiNose, Inc.; Pfizer, Inc.; Becton, Dickinson and Company; Promius Pharma LLC; B.F. Ascher & Company, Inc.; and Cadila Pharmaceuticals Ltd.

Grand View Research has segmented the global nasal drug systems market on the basis of dosage forms, container type, therapeutic application, and region:

Nasal Drug Delivery Systems Dosage Forms Outlook (Revenue, USD Billion, 2014 – 2025)

• Spray

• Drops

• Gel

• Powder

Nasal Drug Delivery Systems Container Type Outlook (Revenue, USD Billion, 2014 – 2025)

• Pressurized Container

• Non-pressurized Container

Nasal Drug Delivery Systems Therapeutic Application Outlook (Revenue, USD Billion, 2014 – 2025)

• Nasal Congestion

• Rhinitis

• Asthma

• Others

Nasal Drug Delivery Systems Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

• Asia Pacific

  • Japan

  • China

  • India

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

• South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/nasal-drug-delivery-technology-system-market